Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]

Leuk Res. 2023 May:128:107068. doi: 10.1016/j.leukres.2023.107068. Epub 2023 Apr 16.
No abstract available

Publication types

  • Published Erratum